Davies Stephen G, Fletcher Ai M, Foster Emma M, Houlsby Ian T T, Roberts Paul M, Schofield Thomas M, Thomson James E
Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.
Org Biomol Chem. 2014 Dec 7;12(45):9223-35. doi: 10.1039/c4ob01737d.
Concise asymmetric syntheses of (-)-lupinine, (+)-isoretronecanol, (+)-5-epi-tashiromine and (R,R)-1-(hydroxymethyl)octahydroindolizine (the azabicyclic core within stellettamides A-C) have been achieved in 8 steps or fewer from commercially available starting materials. The key steps in these syntheses involved the preparation of enantiopure β-amino esters, upon conjugate addition of lithium (R)-N-(p-methoxybenzyl)-N-(α-methyl-p-methoxybenzyl)amide to either ζ-chloro or ζ-hydroxy substituted tert-butyl (E)-hept-2-enoate, or ε-chloro or ε-hydroxy substituted tert-butyl (E)-hex-2-enoate. Activation of the ω-substituent as a leaving group led to SN2-type ring-closure, which occurred with concomitant N-debenzylation via an E1-type deprotection step, to give the corresponding pyrrolidine or piperidine in good yield. Subsequent alkylation of these enantiopure azacycles, followed by a second ring-closure/concomitant N-debenzylation step formed the pyrrolizidine, indolizidine or quinolizidine motif, and reduction with LiAlH4 gave the target compounds in diastereoisomerically and enantiomerically pure form.
从市售起始原料出发,已在8步或更少步骤中实现了(-)-羽扇豆碱、(+)-异瑞特灵、(+)-5-表-塔希罗马宁和(R,R)-1-(羟甲基)八氢吲哚嗪(斯氏酰胺A-C中的氮杂双环核心)的简洁不对称合成。这些合成中的关键步骤包括制备对映体纯的β-氨基酯,即将锂(R)-N-(对甲氧基苄基)-N-(α-甲基-对甲氧基苄基)酰胺共轭加成到ζ-氯或ζ-羟基取代的叔丁基(E)-庚-2-烯酸酯,或ε-氯或ε-羟基取代的叔丁基(E)-己-2-烯酸酯上。将ω-取代基活化作为离去基团导致SN2型闭环反应,该反应通过E1型脱保护步骤伴随N-脱苄基化同时发生,以良好产率得到相应的吡咯烷或哌啶。这些对映体纯的氮杂环随后进行烷基化,接着进行第二步闭环/伴随的N-脱苄基化步骤,形成吡咯里西啶、吲哚里西啶或喹诺里西啶基序,并用LiAlH4还原得到非对映体纯和对映体纯形式的目标化合物。